Testing effectiveness (Phase 2)Ended earlyNCT01961583What this trial is testing[18F]Fluciclatide PET Imaging of Pazopanib ResponseWho this might be right forKidney Neoplasm Asan Medical Center 12
Early research (Phase 1)Study completedNCT00002854What this trial is testingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerWho this might be right forCancer City of Hope Medical Center 33
Very early researchLooking for participantsNCT07067905What this trial is testingClinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma and Glioblastoma Chinese PLA General Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05672459What this trial is testingA Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid TumorsWho this might be right forSolid Tumor M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)UnknownNCT00030888What this trial is testingUCN-01 in Treating Patients With Advanced or Metastatic Kidney CancerWho this might be right forKidney Cancer University of California, San Francisco
Not applicableStudy completedNCT02921802What this trial is testingSpecial Use Results Surveillance of Revlimid 5mg CapsulesWho this might be right forMultiple MyelomaMyelodysplastic Syndromes Celgene 4,626
Testing effectiveness (Phase 2)UnknownNCT02689167What this trial is testingStudy to Assess Various Sunitinib Schedules in Renal Cell CarcinomaWho this might be right forKidney NeoplasmsMetastatic Renal Cell Cancer Centre Hospitalier Universitaire de Besancon 226
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07023432What this trial is testingBelzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)Who this might be right forActive SurveillanceClear Cell Renal Cell Carcinoma M.D. Anderson Cancer Center 78
Testing effectiveness (Phase 2)UnknownNCT05879471What this trial is testing68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forMetastatic Clear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 39
Testing effectiveness (Phase 2)WithdrawnNCT05564416What this trial is testingTesting Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA TrialWho this might be right forBladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01775930What this trial is testingCarfilzomib in Refractory Renal Cell Carcinoma (RCC)Who this might be right forKidney Cancer M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT03233204What this trial is testingOlaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more National Cancer Institute (NCI) 6
Large-scale testing (Phase 3)Active Not RecruitingNCT03091192What this trial is testingSavolitinib vs. Sunitinib in MET-driven PRCC.Who this might be right forCarcinomaCarcinoma, Renal CellKidney Neoplasms+5 more AstraZeneca 60
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 535
Testing effectiveness (Phase 2)Study completedNCT01158521What this trial is testingPazopanib Hydrochloride Before Surgery in Treating Patients With Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell Cancer+1 more Case Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT03907657What this trial is testingContrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel LindauWho this might be right forVon-Hippel LindauKidney Disease, Chronic UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)UnknownNCT00036712What this trial is testingLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+9 more Medical College of Wisconsin 80
Not applicableStudy completedNCT00617799What this trial is testingBiomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaWho this might be right forKidney CancerMelanoma (Skin) University of Nebraska 15
Testing effectiveness (Phase 2)Study completedNCT00496301What this trial is testingClinical Trial on the Mixture of G, C and S in Treatment of Patients With RCCWho this might be right forCarcinoma, Renal Cell Spanish Oncology Genito-Urinary Group 40
Not applicableStudy completedNCT06883565What this trial is testingTertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort StudyWho this might be right forRenal Cell Carcinoma (RCC) Ding-Wei Ye 232